Neurodevelopment in early treated HIV‐infected infants participating in a developmental stimulation programme compared with controls.

Background: Neurodevelopmental stimulation programmes can improve developmental outcomes. Antiretroviral therapy (ART) started soon after birth potentially limits the invasion of HIV into the central nervous system. A combination of developmental stimulation and early ART initiation may reduce devel...

Descripción completa

Detalles Bibliográficos
Publicado en:Child: Care, Health & Development Vol. 47; no. 2; pp. 154 - 163
Autores principales: Strehlau, Renate, Burke, Megan, Aswegen, Tamryn, Kuhn, Louise, Potterton, Joanne
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell Mar2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=148454121&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 148454121
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        03051862
        6NX
      jtl: Child: Care, Health & Development
      issn: 03051862
      maglogo: Y
    pubinfo:
      dt: Mar2021
      vid: 47
      iid: 2
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        148454121
        148454121
        148575985
        148454121
        10.1111/cch.12828
        148454121
      ppf: 154
      ppct: 9
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Neurodevelopment in early treated HIV‐infected infants participating in a developmental stimulation programme compared with controls.
      aug:
        au:
          Strehlau, Renate
          Burke, Megan
          Aswegen, Tamryn
          Kuhn, Louise
          Potterton, Joanne
        affil: Empilweni Services and Research Unit, Rahima Moosa Mother and Child Hospital, Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
      sug:
        subj:
          HIV Infections Drug Therapy
          Anti-Retroviral Agents Therapeutic Use
          Early Childhood Intervention Methods
          Infant Stimulation Methods
          Neurodevelopment In Infancy and Childhood
          Program Evaluation
          Human
          Infant, Newborn
          Infant
          Child, Preschool
          South Africa
          Scales
          Motor Skills Evaluation
          Cognition Evaluation
          Outcome Assessment
          Infant, Newborn: birth-1 month
          Infant: 1-23 months
          Child, Preschool: 2-5 years
      ab: Background: Neurodevelopmental stimulation programmes can improve developmental outcomes. Antiretroviral therapy (ART) started soon after birth potentially limits the invasion of HIV into the central nervous system. A combination of developmental stimulation and early ART initiation may reduce developmental delays in children with perinatally acquired HIV infection. Methods: At a single site in Johannesburg, South Africa, we enrolled 36 HIV‐infected neonates on ART into an intervention group (IG) participating in a yearlong home‐based, neurodevelopmental stimulation programme. Bayley Scales of Infant and Toddler Development‐3rd Edition (BSID‐III) assessments were conducted at 12 months. Scores were compared with 24 early treated HIV‐infected infants in an observational group (OG). BSID‐III assessments were also conducted for older children in an OG at 24 or 36 months. Cognitive, language and motor scaled and composite scores were analysed. Results: BSID‐III scaled and composite scores were all higher in the IG apart from the gross motor scaled score (9.25 vs. 10, p = 0.1954). Receptive communication scaled score was significantly higher in the IG (10.96 vs. 9, p = 0.0331). IG composite scores were all higher than OG scores. OG children assessed at 24 or 36 months had lower composite scores in all subscales than 12‐month OG scores. Conclusions: Early treated HIV‐infected children participating in a neurodevelopmental stimulation programme achieved higher BSID‐III scores at 12 months compared with early treated HIV‐infected children who did not receive the programme.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N